ETFs ResMed, Inc.

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 06/03/2026 GMT			5-day change	1st Jan Change
252.87 ^USD	-0.96%		-1.32%	+4.98%

03-05	Resmed Insider Sold Shares Worth $520,440, According to a Recent SEC Filing	MT
03-04	ASX Biggest Gainers	MT

ETFs positioned on ResMed, Inc.

Name	Varia. Jan 1.	Weight	AuM
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	-1.01%	1.09%	26 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD	-.--%	0.43%	4 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	0.00%	0.38%	2 M€
HARTFORD DISCIPLINED US EQUITY ETF - USD	-0.09%	0.33%	132 M€
GOLDMAN SACHS ACTIVEBETA PARIS-ALIGNED SUSTAINABLE US LARGE CAP EQUITY UCITS ETF - USD	-2.88%	0.21%	152 M€
SYGNIA ITRIX S&P 500 ETF	-2.33%	0.1%	32,064 M€

1 2 3

ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.

Employees

10,600

Sector

Advanced Medical Equipment & Technology

More about the company